A multicenter, randomized controlled trial of SHR1701 combined with GEMOX in treatment of biliary malignant tumor
Latest Information Update: 02 Dec 2020
At a glance
- Drugs Retlirafusp alfa (Primary) ; Gemcitabine; Oxaliplatin
- Indications Biliary cancer; Carcinoma
- Focus Therapeutic Use
- 02 Dec 2020 New trial record